retatrutide trial news today Retatrutide vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness

Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can

23.36

★★★★☆4.8 (126)

Retatrutide Phase 3 Trial for Obesity and Overweight Completes Primary Study

22.96

★★★★★4.9 (98)

A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes

27.89

★★★★★5.0 (157)

Today we shared new results on retatrutide, an investigational, first-of-its-kind treatment we're studying in adults with obesity or overweight with at least one weight-related comorbidity. Read more about the Phase 3 findings:

22.97

★★★★★4.7 (84)

🚨The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today 🚨

24.85

★★★★★4.9 (203)

What GLP‑3 Really Is: Retatrutide Triple‑Receptor Drug

26.83

★★★★★5.0 (176)

Phase 2 Trial of Retatrutide for Obesity

24.94

★★★★★4.8 (132)